AXQ Capital
LENZ icon

AXQ Capital’s LENZ Therapeutics LENZ Stock Holding History

AXQ Capital’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$112K Buy
29,255
+16,511
+130% +$82.2K 0.01% 864
2026
Q2 		$72.4K Sell
12,744
-41,824
-77% -$337K 0.01% 885
2026
Q1 		$499K Buy
54,568
+34,729
+175% +$488K 0.06% 418
2025
Q4 		$317K Buy
19,839
+14,741
+289% +$430K 0.07% 425
2025
Q3 		$237K Buy
+5,098
New +$187K 0.09% 396

Other funds holding LENZ

Alpha Wave Global
Alpha Wave Global New York $4.27B AUM 12.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Versant Venture Management
Versant Venture Management San Francisco, California $109M AUM 43.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AXQ Capital's LENZ Position: Q3 2026 in Review

AXQ Capital increased its LENZ Therapeutics (LENZ) stake by 130% in Q3 2026, buying an estimated $82.2K and bringing the position to 29,255 shares worth $112K. The position accounts for 0.01% of the portfolio, ranked #864.

AXQ Capital first reported a position in LENZ in Q3 2025 and has held it in 5 quarters since. The position peaked at $499K in Q1 2026. 91 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • AXQ Capital held 29,255 shares of LENZ Therapeutics worth $112K as of Q3 2026.
  • AXQ Capital bought 16,511 LENZ Therapeutics shares in Q3 2026, an estimated $82.2K.
  • LENZ Therapeutics made up 0.01% of AXQ Capital's portfolio in Q3 2026, its #864 holding.
  • AXQ Capital first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • AXQ Capital's LENZ Therapeutics position peaked at $499K in Q1 2026.
  • 91 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.